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Abstract
The cAMP response element binding protein (CREB) plays key roles in differentiation of embryonic skeletal muscle
progenitors and survival of adult skeletal muscle. However, little is known about the physiologic signals that activate CREB
in normal muscle. Here we show that CREB phosphorylation and target genes are induced after acute muscle injury and
during regeneration due to genetic mutation. Activated CREB localizes to both myogenic precursor cells and newly
regenerating myofibers within regenerating areas. Moreover, we found that signals from damaged skeletal muscle tissue
induce CREB phosphorylation and target gene expression in primary mouse myoblasts. An activated CREB mutant
(CREBY134F) potentiates myoblast proliferation as well as expression of early myogenic transcription factors in cultured
primary myocytes. Consistently, activated CREB-YF promotes myoblast proliferation after acute muscle injury in vivo and
enhances muscle regeneration in dystrophic mdx mice. Our findings reveal a new physiologic function for CREB in
contributing to skeletal muscle regeneration.
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Introduction
Vertebrate myogenesis is controlled by cascades of muscle-specific
transcription factors, which dictate myogenic specification and
differentiation, as well as repair of damaged adult skeletal muscle
[1]. The second messenger cAMP and the cAMP-responsive
transcription factor CREB are temporally regulated during myogen-
esis and required for somite development in mouse embryos [2,3,4].
Agents that induce cAMP signaling improve muscle strength in
humans and mice with muscle disease [5], but little is known about
how cAMP-dependent transcription in myogenic precursor cells may
contribute to regeneration of damaged adult muscle.
Numerous extracellular signals including those that increase
cAMP induce CREB phosphorylation on a conserved serine
residue (Ser133) that is required for recruitment of the related
histone acetyltransferases CBP/p300 [reviewed in 6]. Although it
is currently unknown what signals induce CREB(S133) phosphor-
ylation in myoblasts within adult skeletal muscle, genetic studies in
mice have shown that CREB activity is required for muscle
development and survival. Genetic deletion of Creb or expression
of a dominant CREB inhibitor termed A-CREB impairs myotome
development in mice, possibly via regulation of the myogenic
regulators Pax3 and Myf5 [2]. Additionally, transgenic expression
of A-CREB in mature myofibers causes muscle degeneration [7].
CREB promotes survival of differentiated muscle by transcrip-
tional induction of the target gene salt inducible kinase 1 (Sik1),
which couples CREB and MEF2 transcription by direct phos-
phorylation and inhibition of class II histone deacetylases [7].
CREB has also been shown to regulate RB [8] and follistatin [9]
transcription during myogenic differentiation, suggesting that
CREB is involved in terminal cell cycle arrest and fusion during
myogenesis. Together these findings show that CREB is an impor-
tant regulator of multiple stages of muscle differentiation and
survival, likely via distinct sets of target genes.
Myogenic differentiation not only occurs during muscle
development, but also during muscle regeneration [1]. Upon
acute muscle injury or damage due to genetic mutations, resident
muscle stem cells, or satellite cells, become activated, proliferate,
migrate to the site of damage and fuse with each other and existing
myofibers to restore muscle structure. Injured muscle releases
numerous signaling molecules including growth factors (HGF,
FGFs, PDGF), Wnts, TGF-beta family ligands, and G-protein
coupled receptor ligands [1,10]. These signals promote regener-
ation in part by activating quiescent satellite cells and providing
homing cues for migrating myoblasts and macrophages. As many
of these signals activate CREB [6] and CREB activity is required
for myogenic differentiation during embryogenesis [2], CREB
is ideally situated to mediate regenerative responses to signals
released in damaged skeletal muscle. However, it is still unknown
whether CREB activity is dynamically regulated in myoblasts after
muscle injury and how CREB contributes to muscle regeneration.
Mouse models with persistent CREB inhibition do not permit
analysis of CREB action in this dynamic setting, so we tested the
hypothesis that CREB activation contributes to regeneration using
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CREB. We show that CREB phosphorylation and target genes are
activated in response to skeletal muscle injury and that activated
CREB drives myoblast proliferation. Moreover, genetic activation
of CREB promotes proliferation after acute muscle damage and
regeneration in mice with muscular dystrophy. Our data support a
model in which CREB promotes satellite cell proliferation and
skeletal muscle regeneration after muscle injury.
Results and Discussion
CREB is activated in response to muscle damage
To characterize the role of CREB in skeletal muscle regenera-
tion, we injected the snake venom component cardiotoxin into
mouse gastrocnemius muscles. Cardiotoxin is commonly used to
induce muscle regeneration in experimental models [1]. After
cardiotoxin injection, skeletal muscle degeneration and regener-
ation occur by a well-characterized process of myofiber necrosis,
satellite cell activation and differentiation, myoblast proliferation
and migration, and eventual myofiber regeneration [11]. Within
three days of cardiotoxin injury, we observed striking induction of
phosphorylated CREB(Ser133) in the injured areas (Figure 1A and
Figure S1A,B), which are evident as large regions of mononucleate
cells. These regions are comprised of proliferating myoblasts [11]
and infiltrating immune cells [12]. To monitor CREB transcrip-
tional activity, we quantified mRNAs of two direct CREB target
genes in muscle cells, Sik1 and Nr4a2 [7]. Both of these genes have
been previously shown to contain consensus CREB binding sites
that are occupied by CREB and phospho-CREB in multiple cell
types [13,14,15], including C2C12 myoblasts [7]. Moreover, acute
induction of these genes is blocked in myoblasts and other cell
types by the dominant CREB inhibitor A-CREB [7]. In skeletal
muscle, Sik1 mediates CREB-dependent myofiber survival [7].
Although Nr4a2 is induced by adrenergic agonists in muscle cells
[reviewed in 16], the role of this orphan nuclear receptor in muscle
physiology is unknown. Consistent with our results showing
phosphorylated CREB in injured skeletal muscle tissue, we found
that cardiotoxin treatment induced Sik1 and Nr4a2 mRNAs, which
peaked 3 days post-injury (Figure 1B and not shown). This time
point corresponds to the period of rapid myoblast proliferation
[17].
Cardiotoxin injection into the gastrocnemius muscle causes
local skeletal muscle degeneration and regeneration, leaving a
substantial amount of the muscle tissue intact (not shown). To
determine whether CREB target gene mRNA induction was
localized to the damaged region of the skeletal muscle, we
performed in situ hybridization with an antisense probe to the
Nr4a2 transcript [18]. We found that Nr4a2 expression was
Figure 1. CREB is activated by muscle injury. A) Immunohistochemistry with anti-pCREB(S133) antibody shown on uninjured and injured
contralateral muscles 3 days after cardiotoxin (CTX) injection; inset, no primary antibody control (npc). B) CREB target gene mRNAs Sik1 and Nr4a2 in
mouse gastrocnemius muscle 3 days after CTX injection. Relative mRNA amounts to 18 S rRNA, normalized to naı ¨ve muscle. n=2 naı ¨ve, 3 CTX.
* p,.05, ** p,.01. Similar data were obtained on an independent cohort. C) In situ hybridization with Nr4a2 antisense riboprobe on uninjured and 3
day CTX-injected contralateral legs; no riboprobe control (blank, inset). D) Phospho-CREB immunohistochemistry and npc on gastrocnemius muscle
from a 4-week old Dmd
mdx mouse. E) Sik1 mRNA in wild-type and Dmd
mdx gastrocnemius tissue from 4-week old mice. mRNA normalized to Gapdh,
averaged by genotype (6stdev); n=6 WT, 6 Dmd
mdx;* *p,.01. F) In situ hybridization with antisense Nr4a2 riboprobe or blank (control) on Dmd
mdx
gastrocnemius at 4 weeks of age. G) Immunofluorescence staining of Dmd
mdx gastrocnemius (4 wk) showing pCREB (green), Pax7 (red) and merge.
Filled arrowheads, co-localized Pax7 and pCREB; open arrowheads, Pax7-positive nuclei without high pCREB; dotted circles, centrally nucleated
myofibers. Bars, 50 mm (A, C, D, F), 10 mm (G).
doi:10.1371/journal.pone.0024714.g001
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phospho-CREB. Control serial sections incubated with no ribop-
robe showed no staining (Figure 1C, inset). We confirmed that the
probe matched the previously reported pattern of Nr4a2
expression in P14.5 mouse embryos [not shown and 18].
We next investigated whether CREB activation is a general
feature of regenerating skeletal muscle. Several genetic mutations
in mice and humans result in skeletal muscle degeneration and
regeneration; many are clinically relevant, such as the missense
mutation in the Dystrophin gene that underlies Duchenne’s
muscular dystrophy [19,20]. We therefore tested CREB activity
in skeletal muscle of dystrophin-deficient Dmd
mdx mice, a genetic
model of muscular dystrophy in which a ‘‘crisis’’ of myofiber
degeneration and regeneration occurs at 4 weeks of age [21].
Although animals at this age invariably show dramatic muscle
degeneration and regeneration, the tissue architecture is hetero-
geneous within a given muscle. Some regions are highly
infiltrated with inflammatory cells and regenerating, while others
appear histologically normal. Similar to our findings in
cardiotoxin injured muscle, phosphorylated CREB was enriched
in regenerating areas of Dmd
mdx skeletal muscle from 4-week old
animals (Figure 1D). Moreover, Sik1 mRNA was increased in
muscle tissue from 4-week old dystrophin-deficient animals
compared with age-matched wild-type control mice (Figure 1E).
Nr4a2 mRNA was also abundant in regenerating regions of
skeletal muscle from 28 day-old Dmd
mdx mice (Figure 1F). This
pattern was markedly similar to the Nr4a2 expression pattern we
observed in skeletal muscle after cardiotoxin injury. Thus, CREB
phosphorylation and transcriptional activity are enriched in
regenerating skeletal muscle after acute injury or degeneration
due to genetic mutation.
CREB is activated in both myogenic precursor cells and
regenerating myofibers
Many cell types are activated in regenerating skeletal muscle
[1], so we performed dual-labeling experiments to identify the cell
type in which CREB is activated in injured skeletal muscle.
Because cardiotoxin-induced CREB target gene activation coin-
cided with the peak time point of myoblast proliferation, we
hypothesized that CREB becomes activated in proliferating
myoblasts. The strong unspecific staining with mouse antibodies
on necrotic cardiotoxin-injured tissue precluded reliable dual-label
analysis in this model (not shown). As expected, we observed
enriched phospho-CREB in regenerating areas of Dmd
mdx muscle
(4-week old) by immunofluorescence (Figure 1G and Figure S1C).
Consistent with our hypothesis, we observed that some, but not all,
Pax7-expressing satellite cells in regenerating mdx muscle con-
tained high levels of phosphorylated CREB (Figure 1G and Figure
S1C, arrowheads). Phosphorylated CREB was not limited to this
cell type. Indeed, we observed strong staining in newly regenerated
myofibers, which we identified by the characteristic central nuclei
(Figure 1G and Figure S1C, dotted circles). It is possible that the
unidentified mononucleate cells with high phospho-CREB staining
are differentiating myocytes that lost Pax7 expression or are
infiltrating macrophages and neutrophils. The strong phospho-
CREB staining in newly regenerated myofibers suggests that
CREB may play a role in differentiating myocytes during myofiber
regeneration. This notion is consistent with previous observations
that CREB activity is elevated during myogenic differentiation of
C2C12 myoblasts [8]. Further experiments will be required to
fully identify the cell type(s) within injured muscle in which CREB
and its target genes are activated. Nonetheless, our data show for
the first time that CREB phosphorylation is induced in myogenic
precursors and nascent myofibers in regenerating skeletal muscle.
Factors released from crushed muscle activate CREB in
primary skeletal myoblasts
Having observed elevated CREB activity in regenerating
skeletal muscle, we hypothesized that after injury, CREB contri-
butes to myoblast activation and/or differentiation. To specifi-
cally investigate CREB action in myogenic cell populations, we
cultured primary mouse myoblasts, which comprise the cell type
that divides and differentiates to form new myofibers. As
expected, CREB phosphorylation on Ser133 in these cells was
induced by application of forskolin (FSK), which elevates
intracellular cAMP, or basic fibroblast growth factor (bFGF),
which is a potent myoblast mitogen (Figure 2A). To directly test
whether CREB is activated in myoblasts in response to stimuli
released from damaged muscle, we treated primary myoblasts
with extracts from mouse skeletal muscles crushed ex vivo. Similar
preparations have previously been shown to induce satellite cell
activation [22], proliferation [23] and migration [10]. Crushed
muscle extract (CME) rapidly induced CREB phosphorylation in
myoblasts (Figure 2B and Figure S2A). Intriguingly, we
consistently recovered more total CREB after 5 and 10 minutes
of CME treatment compared to untreated control myoblasts
(Figure 2B and Figure S2B), although the molecular mechanism
is unknown. Acute changes in total CREB levels are not
commonly observed upon acute cellular treatments, such as
FSK or bFGF (Figure 2A, center). In other cell types, CREB
translation [24] or degradation [25,26] can be modulated by
extracellular stimuli on the order of hours. Possible regulation of
CREB protein abundance in myocytes will be an interesting
avenue for further study.
CREB phosphorylation is necessary but not sufficient for
activation of CREB target genes [27]. We therefore tested
whether CREB phosphorylation in CME-treated myoblasts
correlates with increased CREB transcriptional activity. In
agreement with increased CREB(S133) phosphorylation, the
CREB target genes Sik1 and Nr4a2 increased in primary
myoblasts treated for 1 hour with CME (Figure 2C). We used
the dominant-negative CREB polypeptide A-CREB [28] to verify
that CREB is necessary for Sik1 and Nr4a2 mRNA activation by
crushed muscle extract. Infection of skeletal myoblasts with
adenovirus expressing GFP had little effect on activation of Sik1
and Nr4a2 transcription in response to cAMP-inducing agents or
crushed muscle extract (Figure 2D and Figure S3). By contrast,
adenoviral delivery of A-CREB severely blunted induction of
both genes (Figure 2D and Figure S3). These findings are
consistent with activation of CREB target genes after cardiotoxin
injection in vivo and support the notion that at least part of the
gene induction we observed in injured areas of skeletal muscle
occurred in myoblasts. It is unknown what protein or small
molecules in CME activates CREB in myoblasts. Numerous
growth factors that could induce CREB phosphorylation are
present in CME, including basic fibroblast growth factor (bFGF)
[23] and an unidentified G-protein coupled receptor ligand [10].
Our data suggest that one of these signals or an unknown factor
released from injured skeletal muscle activates CREB in
myoblasts within damaged muscle.
CREB-YF mice have normal muscle structure
Phosphorylation of CREB on Ser133 promotes recruitment of
CBP/p300 and loosening of chromatin at target gene promoters
[6]. Mutation of the adjacent Tyr134 to Phe (CREBY134F,
Figure 3A) results in enhanced PKA phosphorylation and CBP
recruitment [29]. CREB(Y134F) therefore acts as a gain-of-
function mutant when over-expressed in cells [9,30,31]. To
investigate physiologic effects of activated CREB in vivo without
Activated CREB Promotes Muscle Regeneration
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locus in mice (Figure 3B and Figure S4). Creb
+/+, Creb
+/YF, and
Creb
YF/YF mice were recovered at the expected Mendelian
frequency (Table S1). Wild-type and knock-in mice were visually
indistinguishable, and CREB-YF homozygotes exhibited no
phenotypic abnormalities. We verified that the YF mutation did
not alter CREB protein expression in skeletal muscle (Figure 3C).
In unchallenged animals, we observed no statistically significant
difference in amounts of phospho-CREB between adult Creb
+/+
and Creb
YF/YF skeletal muscles (Figure 3C and Figure S5).
Histological analysis revealed no differences between skeletal
muscles of WT and YF littermates in terms of size or fiber type
distribution (not shown). By contrast, expression of CREB-YF in
C2C12 myoblasts induces expression of follistatin, which promotes
myoblast fusion and myotube hypertrophy in vitro [9]. Addition-
ally, CREB binds directly to the cyctochrome c [32] and Ppargc1a
(encoding PGC1-alpha) promoters [33], and forced expression of
CREB co-activators promotes mitochondrial biogenesis in cul-
tured myocytes [34]. Although we measured a modest increase in
Ppargc1a mRNA levels in Creb
YF/YF muscle, we observed no
difference in myofiber succinate dehydro-
genase activity, exercise endurance or voluntary wheel running in
these mice (not shown). We conclude that although CREB may be
involved in muscle responses to exercise, endogenous expression of
CREB-YF does not lead to an increase in CREB activity sufficient
to promote muscle hypertrophy or mitochondrial biogenesis in vivo.
To assay CREB-YF transcriptional activity, we monitored CREB
target gene expression in primarymyoblastsfromCreb
+/+and Creb
YF/
YF littermates. Under basal conditions, we observed a statistically
significant increase in Nr4a2 mRNA levels (Figure 3D). When
stimulated with saturating concentrations of FSK, primarymyoblasts
of both genotypes had identical maximal expression of Nr4a2 mRNA
(notshown).However,weobservedstrongerNr4a2mRNAinduction
in Creb
YF/YF myoblasts compared to controls upon exposure to a low
concentration of FSK (Figure 3D). Thus, CREB(Y134F) is not a
constitutivelyactivemutant,butismoresensitive to PKAsignaling as
previously shown [29]. This is underscored by the fact that Nr4a2
mRNA levels decline after prolonged FSK treatment in both Creb
+/+
and Creb
YF/YF myoblasts (Figure 3D).
Activated CREB promotes myoblast proliferation
Because we observed striking induction of CREB activity in
regenerating areas of damaged skeletal muscle (Figure 1), we
assessed the effects of the CREB-YF gain-of-function mutation
on myoblast proliferation and differentiation, two processes that
occur as part of muscle regeneration. In growth-curve assays,
CREB-YF myoblasts proliferated faster than CREB-WT myo-
blasts (Figure 4A). Moreover, BrdU-labeling revealed more
dividing myoblasts in primary cultures from Creb
YF/YF muscle
compared with Creb
+/+ control muscle (Figure 4B). This finding is
consistent with previous reports showing reduced cell proliferation
in somites of Creb
2/2 embryos [2]. To explore a potential transcri-
ptional target underlying the enhanced proliferation, we measured
expression of CREB target genes implicated in proliferation. We
observed an increase in Ccna2 mRNA in primary myoblasts from
Creb
YF/YF mice (not shown), which is also evident at the protein
level (Figure 4C). CREB binds to the mouse Ccna2 promoter [35],
suggesting that CREB may directly influence cell cycle progression
in myoblasts. Notably, in response to cardiotoxin injection in
mouse muscle, Ccna2 expression and myoblast proliferation are
maximal after 3 days [17], coincident with peak expression of the
CREB transcriptional targets Sik1 and Nr4a2 (Figure 1B).
Figure 2. CREB is activated by crushed muscle extract in primary myoblasts. A) Phospho-CREB (pCREBS133), pATF1, total CREB and HSP90
in primary skeletal myoblasts treated with FSK/IBMX (cAMP) or bFGF for 10 min. B) pCREB, total CREB and HSP90 in primary skeletal myoblasts treated
with crushed muscle extract (CME) for 0, 5 and 10 min. C) Amounts of Sik1 and Nr4a2 mRNA in primary skeletal myoblasts left untreated or incubated
1 h with PBS or CME. D) A-CREB expression in primary skeletal myoblasts blocks Sik1 and Nr4a2 induction by CME (1 h). In C and D, mRNA is
normalized to Gapdh, represented as fold change above unstimulated (6 stdev). Representative of 3 experiments. For D, treatments were normalized
to GFP, unstimulated for each target gene.
doi:10.1371/journal.pone.0024714.g002
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differentiation through multiple transcriptional targets. During
development, a non-canonical Wnt1-cAMP-PKA-CREB pathway
drives myogenesis in part via activation of Myf5 expression [2].
The mouse Myf5 promoter contains several conserved CREB
binding sites and a TATA box [2,13], so it is likely that CREB
directly induces Myf5 expression. However, CREB binding to the
Myf5 promoter has not been demonstrated. We tested whether
CREB-YF is sufficient to drive Myf5 expression and myogenic
differentiation in primary myoblasts. In spite of the enhanced
proliferation we observed when CREB-YF myoblasts were
cultured in growth medium (Figure 4A, B), CREB-YF cells
exhibited stronger upregulation of MYF5 protein within 6 hours
of incubation in differentiation medium (Figure 4D and Figure
S6A). Similarly, Pax7 was transiently upregulated in both the
CREB-WT and CREB-YF cells, but to a greater extent in the
CREB-YF cells (Figures 4E and Figure S6B). We do not know if
the increased abundance of MYF5 and Pax7 proteins in CREB-
YF cultures reflects the presence of more progenitor cells due to
proliferation or elevated expression due to enhanced CREB
activity on the Myf5 or Pax3 promoters [2].
We tested additional cell cycle and myogenic markers in the
differentiating CREB-WT and CREB-YF cultures. The cell cycle
inhibitor p27 peaked approximately 12 hours later in differenti-
ating CREB-YF myocytes than in CREB-WT controls (Figure 4E
and Figure S6C), perhaps reflecting enhanced proliferation in the
CREB-YF cultures after plating. Intermediate and late myogenic
markers (myogenin, MEF2, myosin heavy chain) increased with
similarly delayed kinetics in CREB-YF myotubes compared to
controls (Figure 4E and Figure S6D-F). The peak amounts of these
proteins were similar between the two genotypes, suggesting that
any promotion of myogenesis by CREB occurs early, possibly as a
result of Myf5 induction. Creb
YF/YF myoblasts ultimately differen-
tiated normally into myotubes that were morphologically indis-
tinguishable from Creb
+/+ cells (Figure 4F). The slight differences in
myotube density in Figure 4F may have resulted from enhanced
proliferation of CREB-YF myoblasts in the 18 hours between
plating and addition of differentiation medium. Together, our
findings show that activated CREB drives both myoblast
proliferation and early steps in myogenic differentiation, perhaps
through direct regulation of genes that drive the cell cycle and
myogenesis, respectively.
Figure 3. CREB-YF enhances myoblast response to cAMP. A) Amino acid sequence of CREB PKA phosphorylation site (Ser133) showing Y134F
mutation. B) Targeting strategy for CREB-YF knock-in strain. Mouse Creb1 locus with Y134 in exon 5 (top); targeting construct inserts neo cassette in
intron 4 and Y134F/StuI mutation (middle); targeted locus contains Y134F mutation. S, B: StuI, BamHI restriction sites. Southern probes indicated. C)
Phospho-CREB, CREB and HSP90 protein in gastrocnemius muscle from Creb
+/+ and Creb
YF/YF mice. n=4 per genotype. D) Nr4a2 mRNA in primary
skeletal myoblasts from wild-type and CREB-YF mice, stimulated with FSK/IBMX for indicated times. Nr4a2 normalized to Gapdh, expressed in
arbitrary units (A.U.). **, p,.01; *, p,.05 between genotypes. Average of 3 experiments 6 stdev.
doi:10.1371/journal.pone.0024714.g003
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mice
We have shown that CREB phosphorylation and CREB target
gene expression are elevated in damaged skeletal muscle and that
activated CREB promotes myoblast proliferation and expression
of early myogenic markers in primary myocytes. Next, we took
advantage of our in vivo CREB gain-of-function mouse model to
determine how increased CREB activity might affect muscle
repair. We first tested whether CREB-YF is sufficient to promote
proliferation in vivo, as it did in cultured myoblasts. In juvenile
animals, we observed no difference in the number of Pax7-positive
nuclei between Creb
+/+ and Creb
YF/YF animals (not shown). Thus,
CREB-YF does not increase the number of resident muscle
progenitor cells in the postnatal growth period. To test whether
CREB-YF promotes proliferation after acute muscle injury, we
injected age-matched adult male CREB-WT and CREB-YF
animals with cardiotoxin to induce a synchronous wave of muscle
degeneration, myoblast proliferation and regeneration. On days 2,
3 and 4 after injury, we administered EdU to label newly
synthesized DNA in proliferating cells [36]. On day 5 after injury,
we collected and analyzed the injured tissue for EdU incorporation
Figure 4. Activated CREB promotes myoblast proliferation and differentiation. A) Growth curve assay of Creb
+/+ and Creb
YF/YF myoblasts
over 5 days. Arrows, medium added. **, p,.01 between genotypes. B) Percent of BrdU-positive nuclei in asynchronous myoblast cultures. Means of
10 fields among 3 replicates. *, p,.05. C) CyclinA and HSP90 protein in asynchronous myoblasts. D) Myf5 and GAPDH control in differentiating Creb
+/+
and Creb
YF/YF myocytes. E) Muscle-specific proteins in Creb
+/+ and Creb
YF/YF myocytes after the indicated times in differentiation medium (DM). MYOG,
myogenin; MHC, myosin heavy chain; GAPDH loading control. F) Phase contrast images of 2 day differentiated Creb
+/+ and Creb
YF/YF myotubes. Bar,
100 mm.
doi:10.1371/journal.pone.0024714.g004
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+/+ and
Creb
YF/YF mice had many proliferating cells in the injured regions,
which were evident as large areas of mononucleate cells (Figure 5A,
dashed outline). The total injured area in fields of Creb
+/+ muscle
was similar to that in Creb
YF/YF muscle (Figure S7). However,
Creb
YF/YF mice had a significant increase in the number of EdU-
positive nuclei per injured area relative to Creb
+/+ controls
(Figure 5B). This finding is consistent with our in vitro data
showing elevated proliferation in cultured CREB-YF myoblasts.
We tested effects of the Creb
YF allele on muscle regeneration by
crossing the Creb
YF/YF mice with mdx mice. The CREB-YF allele
did not restore dystrophin expression (Figure 5C), and degener-
ation proceeded normally in CREB-YF-mdx mice (plasma creatine
kinase: Dmd
mdxCreb
+/+ 1,9616950 U/L; Dmd
mdxCreb
YF/YF 2,2956
267; p=.52). We visualized regenerating myofibers in muscle
sections by embryonic myosin heavy chain (eMHC) staining and
centrally located nuclei (Figure 5D) and observed a significant
increase in the number of regenerating myofibers from CREB-YF-
mdx compared to CREB-WT-mdx controls (Figure 5E). Moreover,
the total cross-sectional area of actively regenerating myofibers
was ,30% greater in Dmd
mdxCreb
YF/YF than control Dmd
mdxCreb
+/+
mice (Figure 5F). These data demonstrate that genetic activation
of CREB promotes myofiber regeneration in dystrophic mdx mice.
It is possible that the enhanced regeneration we observe results
from enhanced proliferation at an earlier time point. Indeed, we
noted a significant increase in the proportion of small diameter
myofibers in some CREB-YF-mdx mice compared to CREB-WT-
mdx controls, but this trend varied among individual animals (not
shown). Alternatively, the skew to smaller myofibers could result
from a defect in myotube fusion, although we did not observe
overt fusion defects in differentiating myocyte cultures. It is also
noteworthy that the intensity of myosin heavy chain staining
varied within regenerating regions, as shown in Figure 5D.
Replacement of the embryonic myosin heavy chain isoform by
adult isoforms at later stages of myofiber regeneration could
account for the reduced overall intensity [37] if CREB-YF-mdx
myofibers were regenerating faster than CREB-WT-mdx myofi-
bers. Variance in eMHC intensity did not impact our quantifi-
Figure 5. CREB promotes proliferation and muscle regeneration in mice. A) EdU-positive nuclei (magenta) and all nuclei (DAPI, blue) in
injured region (below dotted line) of adult male Creb
+/+ and Creb
YF/YF mice 5 days after CTX injection with EdU delivery on days 2–4 after cardiotoxin.
B) Average number of EdU-positive nuclei per injured area (mm
2) in 5 fields per mouse. n=5 mice per genotype, *, p,0.05 by 2-tailed paired t-test. C)
Anti-dystrophin immunohistochemistry in gastrocnemius sections from 4-week old CREB-YF-mdx mice of indicated genotypes. Dystrophin, magenta;
DAPI, green. D) Confocal micrographs of regenerating myofibers in cross-sections of CREB-YF-mdx gastrocnemius tissue from 4-week old mice
visualized by embryonic myosin heavy chain (eMHC, magenta, broken outlines) and central nuclei (DAPI, green, arrow). E) Number of regenerating
myofibers per area (6stdev) in fields representing an entire cross-section of the gastrocnemius muscle from animals of the indicated genotypes (4-
week old). n=6 Dmd
mdxCreb
+/+,5Dmd
mdxCreb
YF/YF;* ,p,.05. F) Percent regenerating myofiber area (6 stdev) in gastrocnemius tissue. n=3
Dmd
mdxCreb
+/+,4Dmd
mdxCreb
YF/YF;* ,p,.05. Bars, 50 mm.
doi:10.1371/journal.pone.0024714.g005
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myofibers (even those with no eMHC staining).
Because our genetic strategy results in CREB-YF expression in
all cells, enhanced CREB activity in other cell types may
contribute to the regenerative phenotype. This is particularly
true of immune cells in which CREB has multiple roles including
activation of cytokine gene expression and promotion of survival,
migration and proliferation [38]. We do not know at which stage
in myogenesis CREB acts to promote regeneration. Many nuclei
in regenerating mdx muscle have readily detectable phospho-
CREB. Some of those nuclei express the satellite cell marker
Pax7, but many other nuclei do not (Figure 1G and Figure S1C).
The strong phospho-CREB staining in central nuclei of newly
regenerated myofibers suggests that perhaps CREB is activated
at multiple stages of muscle regeneration. Further studies
including lineage-tracing analysis will be necessary to resolve
this question.
Our results show that genetic activation of CREB is sufficient to
induce both myoblast proliferation and differentiation in vitro and
proliferation and muscle regeneration in vivo. It is not known which
CREB target genes mediate these phenotypes. The distinct cellular
phenotypes we observed in cultured primary myoblasts correlate
with differential expression of the cell cycle regulator Ccna2 as well
as accumulation of the early myogenic marker MYF5, which have
been previously implicated as CREB target genes [2,35]. These
data suggest that multiple CREB target genes may be involved in
the complex process of muscle regeneration. Additional genetic
studies will reveal the molecular mechanisms and target genes
underlying the effects of CREB on proliferation and regeneration
in injured skeletal muscle.
Together our findings support a model in which CREB is
activated in myoblasts and regenerating myofibers by stimuli
released within damaged skeletal muscle tissue, whereupon CREB
promotes myoblast proliferation and contributes to myofiber
regeneration. We posit that the mechanisms by which CREB
participates in skeletal muscle regeneration are distinct from those
in axon regeneration [39] because muscle regeneration involves
activation, proliferation and differentiation of resident quiescent
stem cells. We are just beginning to uncover CREB-dependent
molecular mechanisms that may contribute to the salutary effects
of cAMP signaling on muscle strength [5] and possibly regenera-
ftion in humans and mice with muscular disease.
Methods
Primary skeletal myoblasts
Myofiber-associated satellite cells and myoblasts were prepared
from neonatal mouse limb muscles as described [40]. Myoblasts
were seeded on Matrigel in DMEM-F10, 20% FCS, 2.5 ng/mL
bFGF (Peprotech). Cells were differentiated in DMEM, 2% horse
serum.
Cell treatments
Myoblasts were treated with forskolin (FSK, EMD Chemicals)/
3-isobutyl-1-methylxanthine (phosphodiesterase inhibitor, IBMX,
Sigma) in DMSO at final concentrations of 1 mM FSK/1.8 mM
IBMX. For bFGF stimulation, myoblasts were starved for 3 h in
DMEM-F10, 3% FBS then treated with recombinant bFGF
(2.5 ng/mL). For crushed muscle extract (CME), isolated gas-
trocnemius muscles of adult mice were crushed with blunt forceps
and incubated in PBS with tumbling 1.5 h, 4uC. Myoblasts were
treated with CME (250 mg/mL) or PBS (equal volume). Myoblasts
were labeled with BrdU (10 mM, 1 h) and analyzed by immuno-
fluorescence, counting .800 cells per condition among 3 sets of
myoblasts.
Adenovirus
Recombinant adenovirus encoding GFP or Flag-A-CREB was
propagated in HEK-293 cells and purified by ultracentrifugation
on CsCl2 density gradients and dialyzed extensively into PBS/10%
glycerol as described [41]. Freshly explanted myoblasts were
allowed to adhere overnight and then infected for 6 hours.
24 hours after infection, efficiency was determined by GFP
expression. Cells were then treated for 1 hr with FSK/IBMX or
CME. The University of Texas Health Institutional Biosafety
Committee approved the use of adenovirus (IBC-09-009).
Protein extracts
Whole cell extracts were prepared from cells and tissue in RIPA
buffer (20 mM HEPES pH7.5, 137 mM NaCl, 0.5% TX-100,
0.1% SDS, 0.5% Na-DOC, 0.5 mM EDTA, 5 mM Na4P2O7,
20 mM beta-glycerol phosphate, 50 mM NaF, 1 mM Na3VO4,P I
cocktail) and concentration measured by BCA assay as described
[7]. For phospho-CREB and total CREB western blots, samples
were resolved on duplicate gels in parallel. pCREB and total
CREB were probed on different blots to prevent misinterpretation
of data due to residual signal or loss of protein after stripping.
HSP90 loading controls were performed for each blot to verify
equal loading; shown for the pCREB blots.
Gene expression
cDNA was prepared and analyzed from total RNA by QPCR as
described [7]. Gene-specific RT was used for 18 S rRNA; oligo-
dT RT was used for other transcripts. Relative mRNA amounts
were normalized in each sample to an internal control and
expressed in arbitrary units or fold change. See Table S2 for
primer sequences.
Antibodies
Rabbit monoclonal phospho-CREB(S133) (87G3), CREB
(48H2) and p27 (D69C12), Cell Signaling; mouse monoclonal
adult myosin heavy chain (MHC) MF20 [42], embryonic (e)MHC
F1.652 [43], myogenin F5D [44] and dystrophin MANDRA clone
7A10 [45], Developmental Studies Hybridoma Bank; MEF2 C-21
[46] and HSP90 C-20 [47], Santa Cruz; BrdU clone B44 [48], BD
Biosciences; CyclinA2 AF5999, R&D Systems; DyLight549-Affini-
Pure F(ab’)2 Donkey anti-mouse IgG (715-506-150) and FITC-
AffiniPure F(ab’)2 Donkey anti-rabbit IgG (711-096-152), Jackson
Immunoresearch.
CREB(Y134F) mice
A targeting vector was constructed from a 10.5-kb genomic
fragment encompassing exons 3–5 of mouse Creb1. Site-directed
mutagenesis was used to introduce the Y134F mutation. Creb
+/YF
mice were backcrossed for 10 generations to C57Bl/6 to obtain
Creb
+/+ and Creb
YF/YF mice. See Materials and Methods S1 for
details.
Animals
Animal experiments performed in this study were specifically
approved by the IACUC Committees of the Salk Institute (01-047,
04-042) and the University of Texas Health (HSC-AWC-08-125,
HSC-AWC-11-096). Breeding of transgenic rodents was also
approved by the UT Health Institutional Biosafety Committee
(IBC-09-009). C57Bl/6 were purchased from Harlan; ICR from
Taconic; Dmd
mdx from Jackson. Cardiotoxin (10 mM, 25 mL per
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10 wk mice. Creb
YF/YF males and Dmd
mdx/mdx females were crossed
to generate the CREB-YF-mdx strain. Double heterozygous
offspring were intercrossed to obtain homozygous mice. Plasma
creatine kinase (CK) activity was measured from EDTA-treated
tail blood of 3.5-week old mice with an enzymatic assay (Cata-
chem, Inc) prior to isolation of muscles from the animals of desired
genotype (28 days old). Genotyping protocols are provided in
Materials and Methods S1. CME was obtained from skeletal
muscles of adult ICR mice (8–24 weeks).
In vivo EdU labeling
Male Creb
+/+ and Creb
YF/YF mice (8 wk) were anesthetized with
isoflurane and gastrocnemius muscles of the right hind limb were
treated with topical lidocaine (0.5%) and injected with cardiotoxin
(10 mM, 25 mL per mouse, Sigma) on day zero of the experiment.
EdU (5 mg/kg in 0.9% saline, Invitrogen) was administered via
subcutaneous injection on days 2, 3, and 4 after cardiotoxin injury,
and tissue was collected on day 5 of the experiment [36].
Ketoprofen (Butler Animal Health Supply) was administered via
subcutaneous injection (5 mg/kg, days 0–1; 2 mg/kg days 2–4).
Isolated muscles were flash frozen in OCT in liquid nitrogen-
cooled isopentane. 8-mm fresh frozen sections through the muscle
belly were collected, fixed for 10 min in 10% buffered formalin
and permeabilized in 0.3% TX-100-PBS for 20 min. EdU-labeled
DNA was detected by manufacturer’s directions using the Click-It
EdU Alexa-647 detection kit (Invitrogen). Sections were washed in
16 PBS and counterstained with DAPI (2 mg/mL). Confocal
images were collected on a Nikon A1R microscope and all visible
EdU-positive nuclei in five fields for each of five animals per
genotype were counted using Nikon NIS Elements software.
Injured areas were identified by visualization of high concentra-
tions of mononucleate cells in the DAPI channel and measured
using Nikon NIS elements software. For each field, the number of
EdU-positive nuclei was normalized to the injured area, then
averaged by genotype (6stdev). The average injured area in mm
2
for each genotype was also calculated.
Immunohistochemistry
Phosphorylated CREB was visualized in 8-mm frozen muscle
sections prepared as described for EdU detection. After permea-
bilization and washing, sections were stained with anti-phospho-
CREB antibody (1:100) using the MOM and ABC-HRP detection
kits with NovaRed substrate (Vector Laboratories). Brightfield
images were obtained on a Nikon 80i microscope with a color
camera and Nikon NIS Elements software using matched light and
exposure settings. For fluorescence detection, the blocking and
antibody dilution buffer was PBS/10% normal goat serum/0.3%
TX-100. Primary antibodies to phospho-CREB and Pax7 (1:100)
were added for 1 hour. Secondary antibody incubations were
sequential: 45 min anti-rabbit (1:500) and 10 min anti-mouse
(1:2000 with 0.05% Tween-20). Sections were washed and
counterstained with DAPI (2 mg/mL) prior to imaging on a Nikon
A1R confocal microscope with sequential laser scanning.
In situ hybridization
In situ hybridization on skeletal muscle sections was performed
using an automated system as described [49] with 4 mg/mL
Proteinase K. An antisense digoxygenin-labeled riboprobe com-
plementary to the mouse Nr4a2 transcript (nucleotides 337–934)
was synthesized by in vitro transcription, used at 300 ng/mL.
Negative controls included no probe and sense probe. The sense
probe exhibited strong unspecific staining in all tissues examined
(embryos and muscle) and was disregarded as an inappropriate
control. The Nr4a2 antisense probe recognized the reported Nr4a2
expression pattern in E14.5 mouse embryos [18,50]. Sections were
imaged using a Nikon 80i microscope with color camera and Nikon
NIS Elements software.
Muscle regeneration
Cross-sections of fresh frozen tissue were stained with an eMHC
antibody using the MOM detection kit (Jackson). Micrographs of
tiled fields representing an entire section through the gastrocne-
mius muscle belly of each mouse were collected (Nikon A1
confocal). Section area, number of regenerating fibers (eMHC
positive or central nucleus) and cross-sectional area of individual
regenerating fibers were measured with Adobe Photoshop. Areas
of myofibers at oblique angles were omitted. The percent regener-
ating area was the sum of individual myofiber areas divided by the
total section area. Values were averaged for age-matched double
homozygous animals irrespective of sex.
Statistics
Significance between means of groups was determined by the 2-
tailed Student’s t-test (Excel).
Supporting Information
Figure S1 Localization of phospho-CREB in muscle
tissue. A) Full panel of no primary control (npc) inset shown in
Figure 1A. B) Phospho-CREB(S133) staining in contralateral legs
of 2 wild-type mice (uninjured and 3d after CTX injury). Bars,
50 mm. C) Phospho-CREB (green) and Pax7 (red) staining in 2
Dmd
mdx mice. Filled arrowheads, Pax7-pCREB double positive
nuclei; open arrowheads, Pax7-positive nuclei with low pCREB
staining; outlines, regenerating myofibers. Bottom row, no primary
control (npc) in the same experiment with matched imaging
settings on serial sections of muscle from animal #3. Bars, 10 mm.
(TIF)
Figure S2 Quantification of western blots in Figure 2B.
A) Ratio of pCREB/total CREB. B) Ratio of total CREB/HSP90.
Data represent averages of normalized intensity among panel
shown in Figure 2B and replicate samples. *, p,.05; ** p,.01.
Data are representative of qualitative analysis of 4 independent
sets of treated cells.
(TIF)
Figure S3 A-CREB blunts expression of cAMP-induced
genes in primary myoblasts. CREB target gene mRNA in
Ad-GFP or Ad-ACREB infected primary myoblasts treated 1 h
with FSK/IBMX (cAMP). mRNA amounts normalized to Gapdh
internal control, expressed as fold difference to GFP, unstimulated
control for each target gene. Data are average 6stdev (measure-
ment error). Data represent 3 independent experiments.
(TIF)
Figure S4 Southern blot of targeted mouse Creb locus.
Southern blot of Creb
+/+ and Creb
+/YF ES cell DNA digested with
BstXI and hybridized to a 39 probe external to the targeting
cassette. 8.7-kb (Creb
YF) and 7.4-kb (Creb
+) bands indicated.
(TIF)
Figure S5 Quantification of western blot data shown in
Figure 3C. Average pCREB/total CREB ratio (6stdev). n=4
mice per genotype.
(TIF)
Figure S6 Quantification of western blot data shown in
Figure 4D, 4E. Densitometric ratios for indicated protein/
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Creb
+/+ (black bars) and Creb
YF/YF (open bars) incubated in
differentiation medium (DM) for the indicated times in hours. A)
MYF5, B) PAX7, C) p27, D) Myogenin (MYOG), E) MEF2, F)
Myosin heavy chain (MHC).
(TIF)
Figure S7 Average injured area after cardiotoxin treat-
ment. Average mononucleated area (mm
2) in cardiotoxin injured
muscle 5 days after injury. Average of 5 fields per mouse 6stdev.
n=5 mice per genotype.
(TIF)
Table S1 Summary of offspring statistics from Creb
+/YF
intercrosses. Sex and genotype data from 20 litters (134 pups) of
Creb
+/YF heterozygous intercrosses. Two pups of unknown geno-
type (but known sex) were excluded from genotype summaries.
Expected offspring ratios are shown. Chi squared probability tests
were applied with 1 (sex) or 2 (genotype) degrees of freedom with
continuity correction as appropriate to determine p values.
(PDF)
Table S2 Oligonucleotide primers utilized for QPCR
assays.
(PDF)
Materials and Methods S1
(PDF)
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